OBJECTIVE: To examine the source of observed lower risk-adjusted mortality for blacks than whites within the Veterans Affairs (VA) system by accounting for hospital site where treated, potential under-reporting of black deaths, discretion on hospital admission, quality improvement efforts, and interactions by age group. DATA SOURCES: Data are from the VA Patient Treatment File on 406,550 hospitalizations of veterans admitted with a principal diagnosis of acute myocardial infarction, stroke, hip fracture, gastrointestinal bleeding, congestive heart failure, or pneumonia between 1996 and 2002. Information on deaths was obtained from the VA Beneficiary Identification Record Locator System and the National Death Index. STUDY DESIGN: This was a retrospective observational study of hospitalizations throughout the VA system nationally. The primary outcome studied was all-location mortality within 30 days of hospital admission. The key study variable was whether a patient was black or white. PRINCIPAL FINDINGS: For each of the six study conditions, unadjusted 30-day mortality rates were significantly lower for blacks than for whites (p<.01). These results did not vary after adjusting for hospital site where treated, more complete ascertainment of deaths, and in comparing results for conditions for which hospital admission is discretionary versus non-discretionary. There were also no significant changes in the degree of difference by race in mortality by race following quality improvement efforts within VA. Risk-adjusted mortality was consistently lower for blacks than for whites only within the population of veterans over age 65. CONCLUSIONS: Black veterans have significantly lower 30-day mortality than white veterans for six common, high severity conditions, but this is generally limited to veterans over age 65. This differential by age suggests that it is unlikely that lower 30-day mortality rates among blacks within VA are driven by treatment differences by race.
OBJECTIVE: To examine the source of observed lower risk-adjusted mortality for blacks than whites within the Veterans Affairs (VA) system by accounting for hospital site where treated, potential under-reporting of black deaths, discretion on hospital admission, quality improvement efforts, and interactions by age group. DATA SOURCES: Data are from the VA Patient Treatment File on 406,550 hospitalizations of veterans admitted with a principal diagnosis of acute myocardial infarction, stroke, hip fracture, gastrointestinal bleeding, congestive heart failure, or pneumonia between 1996 and 2002. Information on deaths was obtained from the VA Beneficiary Identification Record Locator System and the National Death Index. STUDY DESIGN: This was a retrospective observational study of hospitalizations throughout the VA system nationally. The primary outcome studied was all-location mortality within 30 days of hospital admission. The key study variable was whether a patient was black or white. PRINCIPAL FINDINGS: For each of the six study conditions, unadjusted 30-day mortality rates were significantly lower for blacks than for whites (p<.01). These results did not vary after adjusting for hospital site where treated, more complete ascertainment of deaths, and in comparing results for conditions for which hospital admission is discretionary versus non-discretionary. There were also no significant changes in the degree of difference by race in mortality by race following quality improvement efforts within VA. Risk-adjusted mortality was consistently lower for blacks than for whites only within the population of veterans over age 65. CONCLUSIONS: Black veterans have significantly lower 30-day mortality than white veterans for six common, high severity conditions, but this is generally limited to veterans over age 65. This differential by age suggests that it is unlikely that lower 30-day mortality rates among blacks within VA are driven by treatment differences by race.
Authors: William B Weeks; Lewis E Kazis; Yujing Shen; Zhongxiao Cong; Xinhua S Ren; Donald Miller; Austin Lee; Jonathan B Perlin Journal: Am J Public Health Date: 2004-10 Impact factor: 9.308
Authors: S F Jencks; T Cuerdon; D R Burwen; B Fleming; P M Houck; A E Kussmaul; D S Nilasena; D L Ordin; D R Arday Journal: JAMA Date: 2000-10-04 Impact factor: 56.272
Authors: Alfredo J Selim; Graeme Fincke; Dan R Berlowitz; Zhongxiao Cong; Donald R Miller; Xinhua S Ren; Shirley Qian; William Rogers; Austin Lee; A K Rosen; Bernardo J Selim; Lewis E Kazis Journal: J Clin Epidemiol Date: 2004-05 Impact factor: 6.437
Authors: Cheryl P Lynch; Mulugeta Gebregziabher; Carrae Echols; Gregory E Gilbert; Yumin Zhao; Leonard E Egede Journal: J Gen Intern Med Date: 2010-06-08 Impact factor: 5.128
Authors: Leonard E Egede; Cheryl P Lynch; Mulugeta Gebregziabher; Kelly J Hunt; Carrae Echols; Gregory E Gilbert; Patrick D Mauldin Journal: J Gen Intern Med Date: 2012-09-05 Impact factor: 5.128
Authors: Kim Peterson; Johanna Anderson; Erin Boundy; Lauren Ferguson; Ellen McCleery; Kallie Waldrip Journal: Am J Public Health Date: 2018-03 Impact factor: 9.308
Authors: Christopher R Frei; Eric M Mortensen; Laurel A Copeland; Russell T Attridge; Mary Jo V Pugh; Marcos I Restrepo; Antonio Anzueto; Brandy Nakashima; Michael J Fine Journal: BMC Health Serv Res Date: 2010-05-27 Impact factor: 2.655
Authors: Daniel Polsky; Ashish K Jha; Judith Lave; Mark V Pauly; Liyi Cen; Heather Klusaritz; Zhen Chen; Kevin G Volpp Journal: Health Serv Res Date: 2008-03-17 Impact factor: 3.402
Authors: Jeffrey H Silber; Paul R Rosenbaum; Patrick S Romano; Amy K Rosen; Yanli Wang; Yun Teng; Michael J Halenar; Orit Even-Shoshan; Kevin G Volpp Journal: Arch Surg Date: 2009-02